Reminder: one of the major projects initiated by Fondation FondaMental Suisse consists in building a shared biobank and a common clinical database: this will make it possible to identify biomarkers (genetic, epigenetic, endocrine, inflammatory, cognitive, etc.) associated with bipolar disorders, then with OCDhyperactivityborderline personality disordersdepression

Since the last “Interim Report”, Swiss researchers have continued to acquire clinical and biological data from bipolar patients recruited from the University Hospital of Geneva (HUG). At this point, this part of the biobank is composed of biological samples, as well as clinical data from more than 200 patients, and covers a spectrum of pathologies often associated with bipolar disorder, such as attention deficit/hyperactivity disorder or borderline personality disorder. It has also been enriched with data from magnetic resonance imaging (MRI) and electroencephalogram (EEG). In addition, this biobank has data from nearly 100 control subjects that can be compared with data from patients with bipolar and related disorders.
On the scientific level, new interactions have been developed between French and Swiss research groups, particularly in the field of brain neuroimaging. The EEG data of bipolar patients and bipolar risk subjects have been investigated, a study in a editorial policy journal with mention of the Foundation’s support has been accepted for publication. Berchio et al. Eye-gaze processing in the broader bipolar spectrum revealed by electrical neuroimaging: Psychiatry Research Neuroimaging 2019.